<DOC>
	<DOCNO>NCT00973180</DOCNO>
	<brief_summary>The overall objective study test efficacy evidence-based , enhanced Rx container label design improve patient ' understanding instruction use . The investigator conduct randomize controlled trial ( N=960 ) evaluate efficacy enhance Rx container label improve patient ' understand actual prescribed medicine , compare standard label format . Patients type II diabetes and/or hypertension safety-net clinic affiliate one central-fill pharmacy ( Nova Scripts Central - NSC ) receive prescribe medicine location . Recruited subject study randomly assign either intervention ( enhanced Rx container label ) control ( standard Rx label ) . All pill-form , regular dosing schedule medicine , include diabetes hypertensive ( i.e . ACE inhibitor ) medicine associate patient ' treatment label accord study arm central-fill pharmacy . Study subject interviewed time dispense prescribe medicine clinic , three month later ( dispense refill ) , finally nine month baseline ( dispense refill ) . Pharmacy refill data medical record information - link clinic - collect exploratory analysis . Patients ' ability read demonstrate Rx label instruction , include auxiliary warning , primary outcome . Other exploratory outcome measure also measure , include 1 ) adverse effect associate medication use define ) rate physician visit , b ) rate emergency room visit , c ) rate hospitalization hospital admission via emergency room medication side effect ( e.g . hyperglycemia hypoglycemia ) ; 2 ) health outcome measure change baseline hemoglobin A1c ( HbA1c ) blood pressure measurement . Data actual use trial process , review , analyze ( order hypothesis ) , report prepare final month last phase study .</brief_summary>
	<brief_title>Enhanced Prescription Drug Label Improve Patient Understanding Use</brief_title>
	<detailed_description />
	<criteria>Diagnosis Type II diabetes hypertension medical chart . 30 year old . Fluent English . Uncorrectable hear visual impairment . Too ill participate .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Prescription medication understand among diabetic hypertension patient .</keyword>
	<keyword>Prescription medication use among diabetic hypertension patient .</keyword>
	<keyword>Hemoglobin A1c change among diabetic patient .</keyword>
	<keyword>Blood pressure change among hypertension patient .</keyword>
</DOC>